miR-185 suppresses progression of Ewing’s sarcoma via inhibiting the PI3K/AKT and Wnt/β-catenin pathways
Authors:
Open Access
- 1 November 2018
- journal article
- research article
- Published by Taylor & Francis in OncoTargets and Therapy
- Vol. ume 11, 7967-7977
Abstract
Background: miRNAs are confirmed to play essential roles in tumorigenesis and progression of cancers, including Ewing’s sarcoma. miR-185 has been reported to be downregulated in some tumors, whereas the role of miR-185 in Ewing’s sarcoma remains unclear. Purpose: The objective of this study was to investigate the role of miR-185 in the progression and metastasis of Ewing’s sarcoma and explore the associated mechanism. Materials and methods: Ewing’s sarcoma cell line RD-ES was transfected with pCMV-MIR-miR185 vector to upregulate the expression of miR-185. Cell Counting Kit 8 and colony formation assays were used to assess the effect of miR-185 on cell proliferation. The effect of miR-185 on cell migration and invasion was detected by transwell assay. Flow cytometry assay was performed to detect apoptosis rate of RD-ES cells. The protein levels of apoptosis-related proteins was determined using Western blot assay or immunohistochemistry assay. Dual-luciferase reporter assay was used to validate the regulation between miR-185 and its target gene. Results: Upregulation of miR-185 caused significant inhibition on cell growth capacity, migration and invasion of Ewing’s sarcoma cell RD-ES. Besides, upregulation of miR-185 was observed to accelerate cell apoptosis in a mitochondrial pathway through regulating Bcl-2/Bax, Caspase 3, and Caspase 9 in Ewing’s sarcoma in vitro. Moreover, upregulation of miR-185 was found to suppress the PI3K/Akt/mTOR and Wnt/β-catenin pathways in RD-ES cells. Furthermore, we identified that E2F6 was a target gene for miR-185, and the suppression on cell proliferation caused by overexpression of miR-185 was significantly rescued by the upregulation of E2F6 in RD-ES cells. Conclusion: miR-185 is involved in cell growth, motility and survival of Ewing’s sarcoma as a tumor suppressor via suppressing PI3K/Akt/mTOR and Wnt/β-catenin pathways and targeting E2F6.Keywords
This publication has 48 references indexed in Scilit:
- Cellular Mechanisms Controlling Caspase Activation and FunctionCold Spring Harbor Perspectives in Biology, 2013
- Epithelial cell adhesion molecules and epithelial mesenchymal transition (EMT) markers in Ewing's sarcoma family of tumors (ESFTs). Do they offer any prognostic significance?Virchows Archiv, 2012
- Astragaloside IV, a Novel Antioxidant, Prevents Glucose-Induced Podocyte Apoptosis In Vitro and In VivoPLOS ONE, 2012
- A Peptide of SPARC Interferes with the Interaction between Caspase8 and Bcl2 to Resensitize Chemoresistant Tumors and Enhance Their Regression In VivoPLOS ONE, 2011
- Mitochondria in Apoptosis: Bcl-2 Family Members and Mitochondrial DynamicsDevelopmental Cell, 2011
- Ewing sarcoma cells express RANKL and support osteoclastogenesisThe Journal of Pathology, 2011
- Downregulation of miR-205 and miR-31 confers resistance to chemotherapy-induced apoptosis in prostate cancer cellsCell Death & Disease, 2010
- P70S6K 1 regulation of angiogenesis through VEGF and HIF-1α expressionBiochemical and Biophysical Research Communications, 2010
- Identification of MicroRNA-21 as a Biomarker for Chemoresistance and Clinical Outcome Following Adjuvant Therapy in Resectable Pancreatic CancerPLOS ONE, 2010
- Grape seed proanthocyanidins promote apoptosis in human epidermoid carcinoma A431 cells through alterations in Cdki‐Cdk‐cyclin cascade, and caspase‐3 activation via loss of mitochondrial membrane potentialExperimental Dermatology, 2007